These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5148048)

  • 21. Clobutinol: severe cardiac arrhythmias. Old drugs should also be monitored.
    Prescrire Int; 2008 Jun; 17(95):113. PubMed ID: 18630356
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cardiac sympatholetic therapy of functional cardiovascular disorders].
    Holzgartner H; Niemann R; Schmidt U
    Med Welt; 1974 Apr; 25(15):661-2. PubMed ID: 4825497
    [No Abstract]   [Full Text] [Related]  

  • 23. [Bone marrow lesions caused by mercaptoimidazole].
    Klesse P; Krüskemper HL
    Med Klin; 1967 Feb; 62(8):295-9. PubMed ID: 5588388
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of oxprenolol on cardiac intracellular potentials in relation to its anti-arrhythmic, local anaesthetic and other properties.
    Vaughan Williams EM; Papp JG
    Postgrad Med J; 1970 Nov; ():Suppl:22-32. PubMed ID: 5494361
    [No Abstract]   [Full Text] [Related]  

  • 25. [Esophageal injuries caused by alprenolol].
    Carlborg B; Densert O; Kumlien A
    Lakartidningen; 1979 Aug; 76(32-33):2706-8. PubMed ID: 481022
    [No Abstract]   [Full Text] [Related]  

  • 26. Labetalol and alprenolol. A comparative investigation of antihypertensive effect.
    Kofod P; Kjaer K; Vejlø S; Hvidt S
    Postgrad Med J; 1980; 56 Suppl 2():69-74. PubMed ID: 7001423
    [No Abstract]   [Full Text] [Related]  

  • 27. [Heart arrhythmias: their treatment using a beta-adrenergic inhibitor (Ciba 39'089 Ba)].
    de Brito FS; Netto SA; Pereira Cde E; Lion MF
    Arq Bras Cardiol; 1969 Feb; 22(1):19-24. PubMed ID: 5785198
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of hypertension with alprenolol (Corbetan)].
    Charnilas J; Blum I; Eisenberg N; Atsmon A
    Harefuah; 1977 Mar; 92(5):205-8. PubMed ID: 323122
    [No Abstract]   [Full Text] [Related]  

  • 29. Contribution to the clinical evaluation of beta-adrenergic blocking drugs: 1-p-nitrophenyl-2-isopropylaminoethanol (INPEA) as an antagonist of catecholamines in normal persons and in coronary disease patients.
    Piva M; Ongari R
    Arzneimittelforschung; 1968 Feb; 18(2):179-88. PubMed ID: 5695376
    [No Abstract]   [Full Text] [Related]  

  • 30. Alprenolol-induced thrombocytopenia.
    Magnusson B; Rödjer S
    Acta Med Scand; 1980; 207(3):231-3. PubMed ID: 7368989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gas chromatographic determination of the secondary amine alprenolol, as its trifluoroacetyl derivative, at nanogram levels in biological fluids.
    Ervik M
    Acta Pharm Suec; 1969 Jun; 6(3):393-400. PubMed ID: 5824854
    [No Abstract]   [Full Text] [Related]  

  • 32. Practolol in the management of cardiac dysrhythmias in patients anaesthetized with halothane.
    Mathias JA; Payne JP
    Br J Pharmacol; 1970 Nov; 40(3):572P-573P. PubMed ID: 5531865
    [No Abstract]   [Full Text] [Related]  

  • 33. [Experimental study on the use of butidrine in anesthesia].
    Pasqualucci V; Calderazzo AB; Pucciarini LG; Vecchiarelli G
    Acta Anaesthesiol; 1967; 18(6):785-99. PubMed ID: 5633200
    [No Abstract]   [Full Text] [Related]  

  • 34. Therapeut effectiveness of alprenolol on angina pectoris.
    Toyama S; Suzuki K; Yamagami T; Amemiya T
    Naika Hokan; 1969 Aug; 16(8):351-8. PubMed ID: 5389048
    [No Abstract]   [Full Text] [Related]  

  • 35. [A case of agranulocytosis caused by clozapine].
    Lacassin F; Jarrousse B; Glykman J; Abraham A; Guillevin L
    Ann Med Interne (Paris); 1993; 144(7):494-5. PubMed ID: 8141520
    [No Abstract]   [Full Text] [Related]  

  • 36. [Agranulocytosis caused by cinepazide maleate. 2 case reports].
    Chague F; Sgro C; Caillot D; Guy H; Portier C; Louis P; Escousse A
    Therapie; 1987; 42(1):67. PubMed ID: 3590073
    [No Abstract]   [Full Text] [Related]  

  • 37. [Drug-induced (probably allopurinol) agranulocytosis. Case report and discussion].
    Schär B; Meier C; Affolter H
    Schweiz Med Wochenschr; 1994 Apr; 124(13):545-9. PubMed ID: 8171306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A case of agranulocytosis caused by ethoxyd].
    Katslan IaD
    Klin Med (Mosk); 1970 Dec; 48(12):108. PubMed ID: 5518585
    [No Abstract]   [Full Text] [Related]  

  • 39. [Agranulocytosis caused by aprindine. Apropos of a new case].
    González Juanatey JR; Amaro Cendon A; Pose Reino A; Torre Carballada A; Rubio Alvarez J; Gil de la Peña M
    Med Clin (Barc); 1984 May; 82(19):865-6. PubMed ID: 6738221
    [No Abstract]   [Full Text] [Related]  

  • 40. Indications and limits of cardiac beta-receptor blockase: physiopharmacological and clinical considerations on the subject of beta-adrenergic receptor blockade, pure and otherwise.
    Dotti F; Piva M; Ongari R
    Arzneimittelforschung; 1968 Nov; 18(11):1445-8. PubMed ID: 5755911
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.